Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine and postoperative recovery after laparoscopic cholecystectomy
ChiCTR2100054508Phase 4Recruiting
- Sponsor
- Xuzhou Central Hospital
- Start
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of esketamine in benign diseases of the gallbladder (3 arms), sponsored by Xuzhou Central Hospital. Primary endpoint: Postoperative quality of recovery at 24 hours. Started Dec 2021; status: recruiting.
02
Drugs
esketamine
03
Conditions
benign diseases of the gallbladder
Beyond the preview
Go deeper on ChiCTR2100054508.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100054508.